Dr Mohammad Alkhalil Dr Mohaned Egred Dr Richard Edwards Dr Rajiv Das Professor Azfar Zaman et al. | A Systematic Review and Meta-Analysis of the Clinical Outcomes of Isolated Tricuspid Valve Surgery | 2023 |
|
Professor Azfar Zaman
| An Update on Anti-thrombotic Therapy following Transcatheter Aortic Valve Implantation: Expert Cardiologist Opinion from a UK and Ireland Delphi Group | 2023 |
|
Dr Ben Beska Dr Hanna Ratcovich Dr Alan Bagnall Dr Richard Edwards Dr Mohaned Egred et al. | Angiographic and Procedural Characteristics in Frail Older Patients with Non-ST Elevation Acute Coronary Syndrome | 2023 |
|
Dr Bilal Bawamia Professor Ioakim Spyridopoulos Dr Alan Bagnall Dr Mohaned Egred Professor Azfar Zaman et al. | Very Early Discharge After Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction: Mortality Outcomes at Six Months | 2023 |
|
Professor Azfar Zaman
| A Randomized, double-blind, dose ranging clinical trial of intravenous FDY-5301 in acute stemi patients undergoing primary PCI | 2022 |
|
Professor Azfar Zaman
| Clinical outcomes according to lesion complexity in high bleeding risk patients treated with 1-month dual antiplatelet therapy following PCI: Analysis from the Onyx ONE clear study | 2022 |
|
Professor Azfar Zaman
| Clinical Predictors for Procedural Stroke and Implications for Embolic Protection Devices during TAVR: Results from the Multicenter Transcatheter Aortic Valve Replacement In-Hospital Stroke (TASK) Study | 2022 |
|
Dr Mohaned Egred Dr Mohammad Alkhalil Professor Azfar Zaman
| Coronary revascularization in patients with left ventricle systolic dysfunction, current challenges and clinical outcomes | 2022 |
|
Stephen Hoole Professor Azfar Zaman
| Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: final results of the SYNTAX II study | 2022 |
|
Dr Mohaned Egred Professor Azfar Zaman Dr Mohammad Alkhalil
| Mechanical circulatory support in acute myocardial infarction complicated by cardiogenic shock | 2022 |
|
Professor Azfar Zaman
| Patients With Diabetes at High Bleeding Risk With 1-Month Dual Antiplatelet Therapy: Onyx ONE Clear Results | 2022 |
|
Dr Rajiv Das Dr Richard Edwards Professor Azfar Zaman Dr Mohammad Alkhalil
| Prognostic Role of Sex-Specific Flow Threshold in Patients UndergoingTranscatheter Aortic Valve Replacement | 2022 |
|
Dr Sharareh Vahabi Professor Azfar Zaman
| Reducing cardiovascular risk in patients with type 2 diabetes mellitus | 2022 |
|
Professor Azfar Zaman
| Safety and efficacy of Everolimus-Eluting bioabsorbable Polymer-Coated stent in patients with long coronary lesions: The EVOLVE 48 study | 2022 |
|
Dr Salman Razvi Dr Avais Jabbar Professor Azfar Zaman
| Triiodothyronine (T3), inflammation and mortality risk in patients with acute myocardial infarction | 2022 |
|
Professor Azfar Zaman
| ACTIVATION (PercutAneous Coronary inTervention prIor to transcatheter aortic VAlve implantaTION): A Randomized Clinical Trial | 2021 |
|
Dr Jake McClements Dr Katarina Novakovic Professor Azfar Zaman Professor Ioakim Spyridopoulos Professor Marloes Peeters et al. | Immobilization of Molecularly Imprinted Polymer Nanoparticles onto Surfaces using Different Strategies: Evaluating the Influence of the Functionalised Interface on the Performance of a Thermal Assay for the Detection of Cardiac Biomarker Troponin I | 2021 |
|
Professor Azfar Zaman Dr Qaiser Aleem
| Pharmacology before, during and after percutaneous coronary intervention | 2021 |
|
Dr Avais Jabbar Lorna Ingoe Dr Shahid Junejo Dr David Austin Professor Azfar Zaman et al. | Prevalence, Predictors and Outcomes of Thyroid Dysfunction in patients with Acute Myocardial Infarction: the ThyrAMI-1 Study | 2021 |
|
Dr Ben Beska Dr Ashfaq Mohammed Dr Rajiv Das Dr Richard Edwards Professor Azfar Zaman et al. | Role of coronary angiogram before transcatheter aortic valve implantation | 2021 |
|
Dr Mark De Belder Professor Azfar Zaman
| Survival relative to pacemaker status after transcatheter aortic valve implantation | 2021 |
|
Dr Simon Findlay Professor Azfar Zaman
| A comparison of cardiovascular risk scores in native and migrant South Asian populations | 2020 |
|
Dr Avais Jabbar Lorna Ingoe Dr Shahid Junejo Dr Peter Carey Dr Honey Thomas et al. | Effect of levothyroxine on left ventricular ejection fraction in patients with subclinical hypothyroidism and acute myocardial infarction: a randomized clinical trial | 2020 |
|
Dr Mohaned Egred Dr Alan Bagnall Professor Ioakim Spyridopoulos Dr Rajiv Das Professor Azfar Zaman et al. | Effect of Pressure-controlled intermittent Coronary Sinus Occlusion (PiCSO) on infarct size in anterior STEMI: PiCSO in ACS study | 2020 |
|
Professor Azfar Zaman
| One-Month dual antiplatelet therapy following percutaneous coronary intervention with zotarolimus-eluting stents in high-bleeding-risk patients | 2020 |
|
Dr Subhi Akleh Professor Azfar Zaman Dr Rajiv Das Dr Richard Edwards
| Outcomes of Direct Flow Medical vs Sapien 3 Transcatheter Aortic Valve Devices | 2020 |
|
Dr Bilal Bawamia Dr Mohaned Egred Dr Matthew Jackson Dr David Austin Professor Azfar Zaman et al. | Percutaneous coronary intervention for left main stem disease: Impact of diabetes mellitus on mortality | 2020 |
|
Dr Salman Razvi Dr Avais Jabbar Dr Arjola Bano Lorna Ingoe Dr Peter Carey et al. | Sample Timing, Diagnosis of Subclinical Thyroid Dysfunction and Mortality in Acute Myocardial Infarction: ThyrAMI1 Study | 2020 |
|
Professor Azfar Zaman Dr Mohaned Egred Dr Alan Bagnall Dr Jannath Ahmed Dr Richard Edwards et al. | Smoking status and mortality outcomes following percutaneous coronary intervention | 2020 |
|
Professor Azfar Zaman Dr Mark De Belder
| Transcatheter aortic valve implantation via surgical subclavian versus direct aortic access: A United Kingdom analysis | 2020 |
|
Professor Azfar Zaman
| Combinations of bleeding and ischemic risk and their association with clinical outcomes in acute coronary syndrome | 2019 |
|
Professor Azfar Zaman
| Outcomes Following Percutaneous Coronary Intervention in Saphenous Vein Grafts With and Without Embolic Protection Devices | 2019 |
|
Professor Azfar Zaman
| Rationale and design of the Onyx ONE global randomized trial: A randomized controlled trial of high-bleeding risk patients after stent placement with 1 month of dual antiplatelet therapy | 2019 |
|
Professor Azfar Zaman
| Safety and efficacy of a sirolimus-eluting coronary stent with ultra-thin strut for treatment of atherosclerotic lesions (TALENT): a prospective multicentre randomised controlled trial | 2019 |
|
Professor Azfar Zaman
| FDXR is a biomarker of radiation exposure in vivo | 2018 |
|
Professor Azfar Zaman Dr Mohaned Egred Professor Thomas Johnson Dr Mark De Belder
| Acute and one-year clinical outcomes following implantation of bioresorbable vascular scaffolds: The ABSORB UK Registry | 2018 |
|
Professor Azfar Zaman
| Orbita – Much ado about nothing? | 2018 |
|
Dr Sophie Gu Professor Christopher Eggett Dr Hani Ali Professor Azfar Zaman Dr Richard Edwards et al. | Percutaneous Coronary Intervention for Left Ventricular Systolic Dysfunction | 2018 |
|
Professor Azfar Zaman Dr Qaiser Aleem
| Reducing cardiovascular risk in patients with type 2 diabetes mellitus | 2018 |
|
Dr Matthew Jackson Dr David Austin Muhammad Rashid Dr Mark De Belder Professor Azfar Zaman et al. | The impact of diabetes on the prognostic value of left ventricular function following percutaneous coronary intervention: Insights from the British Cardiovascular Intervention Society | 2018 |
|
Dr Salman Razvi Dr Avais Jabbar Professor Azfar Zaman
| Thyroid Hormones and Cardiovascular Function and Diseases | 2018 |
|
Dr Mark De Belder Professor Azfar Zaman
| Choice of Stent for Percutaneous Coronary Intervention of Saphenous Vein Grafts | 2017 |
|
Dr Karthik Balasubramaniam Dr Kelvin Lee Muhammad Rashid Professor Azfar Zaman
| Mortality after percutaneous coronary revascularization: Prior cardiovascular risk factor control and improved outcomes in patients with diabetes mellitus | 2017 |
|
Professor Azfar Zaman
| Observational Study of Platelet Reactivity in Patients Presenting With ST-Segment Elevation Myocardial Infarction Due to Coronary Stent Thrombosis Undergoing Primary Percutaneous Coronary Intervention: Results From the European PREvention of Stent Thrombosis by an Interdisciplinary Global European Effort Registry | 2017 |
|
Dr Mark De Belder Professor Azfar Zaman
| The Relationship of Body Mass Index to Percutaneous Coronary Intervention Outcomes: Does the Obesity Paradox Exist in Contemporary Percutaneous Coronary Intervention Cohorts? Insights From the British Cardiovascular Intervention Society Registry | 2017 |
|
Dr Avais Jabbar Professor Simon Pearce Professor Azfar Zaman Dr Salman Razvi
| Thyroid hormones and cardiovascular disease | 2017 |
|
Professor Azfar Zaman
| Twelve-month results of a prospective, multicentre trial to assess the everolimus-eluting coronary stent system (PROMUS Element): The PLATINUM PLUS all-comers randomised trial | 2017 |
|
Dr Mohaned Egred Dr Ayush Khurana Dr Alan Bagnall Professor Azfar Zaman
| 1-Year Follow-Up Optical Frequency Domain Imaging of Multiple Bioresorbable Vascular Scaffolds for the Treatment of Spontaneous Coronary Artery Dissection | 2016 |
|
Dr Mark De Belder Professor Azfar Zaman
| Changes in Arterial Access Site and Association With Mortality in the United Kingdom: Observations From a National Percutaneous Coronary Intervention Database | 2016 |
|
Professor Azfar Zaman
| Determinants and Outcomes of Stroke Following Percutaneous Coronary Intervention by Indication | 2016 |
|
Professor Azfar Zaman
| Does the Routine Availability of CT-Derived FFR Influence Management of Patients With Stable Chest Pain Compared to CT Angiography Alone?: The FFRCT RIPCORD Study | 2016 |
|
Dr Avais Jabbar Dr Ashfaq Mohammed Dr Ayush Khurana Dr Rajiv Das Professor Azfar Zaman et al. | Local versus general anaesthesia in transcatheter aortic valve replacement – a tertiary centre experience | 2016 |
|
Dr Avais Jabbar Dr Ayush Khurana Dr Ashfaq Mohammed Dr Rajiv Das Professor Azfar Zaman et al. | Local Versus General Anesthesia in Transcatheter Aortic Valve Replacement | 2016 |
|
Professor Azfar Zaman
| Meta-Analysis of the Prognostic Impact of Anemia in Patients Undergoing Percutaneous Coronary Intervention | 2016 |
|
Dr Mark De Belder Professor Azfar Zaman
| Outcomes Following Primary Percutaneous Coronary Intervention in Patients With Previous Coronary Artery Bypass Surgery | 2016 |
|
Professor Azfar Zaman
| P2Y12 receptor inhibitors in patients with non-ST-elevation acute coronary syndrome in the real world: use, patient selection, and outcomes from contemporary European registries | 2016 |
|
Professor Azfar Zaman
| Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial | 2016 |
|
Professor Azfar Zaman
| Primary percutaneous coronary intervention for ST elevation myocardial infarction in nonagenarians | 2016 |
|
Dr Avais Jabbar Dr Ayush Khurana Dr Rajiv Das Professor Azfar Zaman Dr Richard Edwards et al. | Transcatheter aortic valve replacement: a comparison of the direct flow medical and sapien 3 aortic valves | 2016 |
|
Professor Azfar Zaman
| Use, patient selection and outcomes of P2Y12 receptor inhibitor treatment in patients with STEMI based on contemporary European registries | 2016 |
|
Professor Azfar Zaman
| Contemporary registries on P2Y12 inhibitors in patients with acute coronary syndromes in Europe: overview and methodological considerations. | 2015 |
|
Professor Vijay Kunadian Professor Azfar Zaman Dr Mark De Belder
| Effect of access site, gender, and indication on clinical outcomes after percutaneous coronary intervention: Insights from the British Cardiovascular Intervention Society (BCIS) | 2015 |
|
Professor Azfar Zaman
| High Platelet Reactivity in Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: Randomised Controlled Trial Comparing Prasugrel and Clopidogrel | 2015 |
|
Professor Bernard Keavney Professor Azfar Zaman Dr Mark De Belder
| Impact of age on access site-related outcomes in 469,983 percutaneous coronary intervention procedures: Insights from the British Cardiovascular Intervention Society | 2015 |
|
Professor Bernard Keavney Professor Azfar Zaman Dr Mark De Belder
| Impact of Age on the Prognostic Value of Left Ventricular Function in Relation to Procedural Outcomes Following Percutaneous Coronary Intervention: Insights From the British Cardiovascular Intervention Society | 2015 |
|
Professor Vijay Kunadian Dr Murugu Veerasamy Dr Hannah Sinclair Dr Rajiv Das Dr Richard Edwards et al. | Major Adverse Cardiovascular Events at 30-days were not Significantly different between Frail and non-frail older ( ≥75 Years) Patients with non ST Elevation Acute Coronary Syndrome Managed by Invasive Strategy: An Analysis from the ICON1 Study | 2015 |
|
Professor Ioakim Spyridopoulos Dr Javed Ahmed Dr Rajiv Das Dr Richard Edwards Dr Alan Bagnall et al. | Shock-index as a novel predictor of long-term outcome following primary percutaneous coronary intervention | 2015 |
|
Professor Azfar Zaman Professor Bernard Keavney Dr Mark De Belder
| Stroke following percutaneous coronary intervention: type-specific incidence, outcomes and determinants seen by the British Cardiovascular Intervention Society 2007-12 | 2015 |
|
Dr Stephen Boag Dr Rajiv Das Dr Evgeniya Shmeleva Dr Alan Bagnall Dr Mohaned Egred et al. | T lymphocytes and fractalkine contribute to myocardial ischemia/reperfusion injury in patients | 2015 |
|
Dr Avais Jabbar Professor Simon Pearce Professor Azfar Zaman Dr Salman Razvi
| Thyroxine in acute myocardial infarction (ThyrAMI) - levothyroxine in subclinical hypothyroidism post-acute myocardial infarction: study protocol for a randomised controlled trial | 2015 |
|
Dr Karthik Balasubramaniam Professor Azfar Zaman
| Antiplatelet Therapy in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction: A Retrospective Observational Study of Prasugrel and Clopidogrel | 2014 |
|
Dr Karthik Balasubramaniam Dr Girish Viswanathan Professor Azfar Zaman
| Antithrombotic properties of rafigrelide: a phase 1, open-label, non-randomised, single-sequence, crossover study | 2014 |
|
Dr Girish Viswanathan Dr Karthik Balasubramaniam Emerita Professor Sally Marshall Professor Azfar Zaman Dr Salman Razvi et al. | Blood Thrombogenicity is Independently Associated with Serum TSH Levels in Post-Non-ST Elevation Acute Coronary Syndrome | 2014 |
|
Dr Girish Viswanathan Emerita Professor Sally Marshall Dr Karthik Balasubramaniam Professor Azfar Zaman
| Differences in thrombus structure and kinetics in patients with type 2 diabetes mellitus after non ST elevation acute coronary syndrome. | 2014 |
|
Professor Azfar Zaman
| Does Routine Pressure Wire Assessment Influence Management Strategy at Coronary Angiography for Diagnosis of Chest Pain? The RIPCORD Study | 2014 |
|
Dr Stephen Boag Dr Rajiv Das Dr Mohaned Egred Professor Azfar Zaman Dr Alan Bagnall et al. | Dynamic Changes in T-Lymphocyte Counts Following Primary Percutaneous Coronary Intervention Predict Infarct Size and Microvascular Obstruction | 2014 |
|
Professor Bernard Keavney Professor Azfar Zaman Dr Mark De Belder
| Impact of left ventricular function in relation to procedural outcomes following percutaneous coronary intervention: insights from the British Cardiovascular Intervention Society | 2014 |
|
Dr Murugu Veerasamy Dr Alan Bagnall Professor Azfar Zaman
| Multi-vessel coronary artery disease is associated with early, but not late, mortality following primary percutaneous coronary intervention | 2014 |
|
Professor Vijay Kunadian Dr Bilal Bawamia Professor Azfar Zaman
| Outcomes Following Primary Percutaneous Coronary Intervention in the Setting of Cardiac Arrest: A Registry Database Study | 2014 |
|
Professor Azfar Zaman
| Switching from transfemoral to transradial access for PCI: A single-center learning curve over 5 years | 2014 |
|
Dr Girish Viswanathan Dr Karthik Balasubramaniam Professor Azfar Zaman Emerita Professor Sally Marshall
| Thrombogenicity in obese patients with Type 2 diabetes following non ST-elevation acute coronary syndrome: is inflammation the missing link? | 2014 |
|
Dr Karthik Balasubramaniam Dr Rajiv Das Professor Vijay Kunadian Professor Azfar Zaman
| Admission Heart Rate Predicts Mortality Following Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction | 2013 |
|
Dr Karthik Balasubramaniam Dr Rajiv Das Professor Vijay Kunadian Professor Azfar Zaman
| Admission Heart Rate Predicts Mortality Following Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction: An Observational Study | 2013 |
|
Dr Karthik Balasubramaniam Dr Girish Viswanathan Andini Natasari Jessica Tarn Dr Dennis Lendrem et al. | Assessment of blood clot formation and platelet receptor function ex vivo in patients with primary Sjögren’s syndrome | 2013 |
|
Dr Girish Viswanathan Dr Kathryn White Professor Azfar Zaman Emerita Professor Sally Marshall
| Clopidogrel alters thrombus quantity and quality in Type 2 diabetes | 2013 |
|
Professor Vijay Kunadian Dr Bilal Bawamia Professor Azfar Zaman
| Drug eluting stents versus bare metal stents in primary PCI | 2013 |
|
Professor Vijay Kunadian Dr Bilal Bawamia Dr Murugu Veerasamy Sheila Jamieson Professor Azfar Zaman et al. | Gender Comparisons in Cardiogenic Shock During ST Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention | 2013 |
|
Dr Karthik Balasubramaniam Dr Girish Viswanathan Emerita Professor Sally Marshall Dr Salman Razvi Professor Azfar Zaman et al. | Higher Thrombus Burden in Patients with Subclinical Hypothyroidism after Non ST Elevation Acute Coronary Syndrome | 2013 |
|
Professor Azfar Zaman Dr Javed Ahmed Dr Mohaned Egred Professor Ioakim Spyridopoulos Professor Bernard Keavney et al. | Provision of Gastroprotective Medication and Bleeding Risk Following Acute Coronary Syndrome | 2013 |
|
Professor Azfar Zaman Dr Javed Ahmed Dr Mohaned Egred Dr Richard Edwards Professor Ioakim Spyridopoulos et al. | Provision of Gastroprotective Medication and Bleeding Risk Following Acute Coronary Syndrome | 2013 |
|
Dr Girish Viswanathan Dr Karthik Balasubramaniam Dr Bilal Bawamia Emerita Professor Sally Marshall Professor Azfar Zaman et al. | Higher thrombus, altered clot kinetics and fibrin architecture in patients with type 2 diabetes mellitus after non ST elevation acute coronary syndrome | 2012 |
|
Dr Karthik Balasubramaniam Dr Girish Viswanathan Emerita Professor Sally Marshall Professor Azfar Zaman
| Increased atherothrombotic burden in patients with diabetes mellitus and acute coronary syndrome: a review of antiplatelet therapy | 2012 |
|
Professor Vijay Kunadian Professor Azfar Zaman
| Lack of gender difference and improved in-hospital mortality rates in patients with cardiogenic shock following primary percutaneous coronary intervention: a UK tertiary cardiac centre registry study | 2012 |
|
Professor Vijay Kunadian Professor Azfar Zaman
| Lack of gender difference and improved in-hospital mortality rates in patients with cardiogenic shock following primary percutaneous coronary intervention: a UK tertiary cardiac centre registry study | 2012 |
|
Professor Vijay Kunadian Professor Azfar Zaman
| Lack of gender difference and improved in-hospital mortality rates in patients with cardiogenic shock following primary percutaneous coronary intervention: a UK tertiary cardiac centre registry study | 2012 |
|
Professor Vijay Kunadian Professor Azfar Zaman
| Percutaneous coronary intervention among patients with left ventricular systolic dysfunction: a review and meta-analysis of 19 clinical studies | 2012 |
|
Professor Vijay Kunadian Professor Azfar Zaman
| Saphenous vein graft percutaneous coronary intervention via radial artery access: Safe and effective with reduced hospital length of stay | 2012 |
|
Dr Girish Viswanathan Emerita Professor Sally Marshall Dr Karthik Balasubramaniam Professor Azfar Zaman
| Thrombus and antiplatelet therapy in type 2 diabetes mellitus: A prospective study after non-ST elevation acute coronary syndrome and a randomised, blinded, placebo-controlled study in stable angina | 2012 |
|
Dr Girish Viswanathan Professor Azfar Zaman
| Unfractionated Heparin during Elective PCI: Fixed Dose or Weight Adjusted? | 2012 |
|
Professor Azfar Zaman
| Changing Characteristics and Mode of Death Associated With Chronic Heart Failure Caused by Left Ventricular Systolic Dysfunction A Study Across Therapeutic Eras | 2011 |
|
Dr Bilal Bawamia Sheila Jamieson Professor Azfar Zaman
| Evaluating a nurse led triage process in treating patients with left bundle branch block (LBBB) referred for primary percutaneous coronary intervention (pPCI) | 2011 |
|
Dr Bilal Bawamia Sheila Jamieson Professor Azfar Zaman
| Evaluating a nurse-led triage process in treating patients with Left Bundle Branch Block (LBBB) referred for primary Percutaneous Coronary Intervention (pPCI) | 2011 |
|
Dr Bilal Bawamia Sheila Jamieson Professor Azfar Zaman
| Evaluating a nurse-led triage process in treating patients with Left Bundle Branch Block (LBBB) referred for primary Percutaneous Coronary Intervention (pPCI) | 2011 |
|
Dr Girish Viswanathan Anthony Hildreth Professor Azfar Zaman
| Health Related Quality of Life After Percutaneous Coronary Revascularisation in Patients with Previous Coronary Artery Bypass Grafts: A Two-Year Follow Up Study | 2011 |
|
Professor Vijay Kunadian Professor Azfar Zaman
| Revascularization among patients with severe left ventricular dysfunction: a meta-analysis of observational studies | 2011 |
|
Professor Vijay Kunadian Professor Azfar Zaman Professor Ioakim Spyridopoulos
| Sodium bicarbonate for the prevention of contrast induced nephropathy: A meta-analysis of published clinical trials | 2011 |
|
Dr Girish Viswanathan Professor Azfar Zaman
| Better clinical outcomes of participants in clinical research: Trial effect of an observational study in patients with non ST elevation acute coronary syndrome (NSTE-ACS) | 2010 |
|
Professor Azfar Zaman Dr Asif Shah
| Changing Characteristics and Outcomes of Patients with Chronic Heart Failure due to Left Ventricular Systolic Dysfunction: a Study Across Therapeutic Eras | 2010 |
|
Dr Girish Viswanathan Emerita Professor Sally Marshall Professor Azfar Zaman
| Evaluation of Thrombus in Patients with Type 2 Diabetes Mellitus After Non-ST-Elevation Acute Coronary Syndrome (NSTE-ACS): Increased Amount and Altered Strength | 2010 |
|
Dr Girish Viswanathan Dr Arun Natarajan Emerita Professor Sally Marshall Professor Azfar Zaman
| Higher Thrombus Burden and Impaired Clot Kinetics in Patients with Type 2 Diabetes Mellitus following Non ST-Elevation Acute Coronary Syndrome | 2010 |
|
Dr Girish Viswanathan Emerita Professor Sally Marshall Professor Azfar Zaman
| Thrombus burden and response to clopidogrel in patients with type 2 diabets mellitus presenting with non ST elevation acute coronary syndrome | 2010 |
|
Professor Azfar Zaman Emeritus Professor David Mendelow Dr Daniel Birchall
| Analysis of haemodynamic factors involved in carotid atherosclerosis using computational fluid dynamics | 2009 |
|
Dr Sharad Agarwal Professor Azfar Zaman
| Assessment of functional status and quality of life after percutaneous coronary revascularisation in octogenarians | 2009 |
|
Dr Girish Viswanathan Sajid Javed Sheila Jamieson Professor Azfar Zaman
| Guidelines to Practice Gap in the Use of Glycoprotein IIb/IIIa Inhibitors: From ISAR-REACT to Overreact ? | 2009 |
|
Dr Honey Thomas Dr Peter Avery Dr Javed Ahmed Dr Richard Edwards Professor Azfar Zaman et al. | Local vessel injury following percutaneous coronary intervention does not promote early mobilisation of endothelial progenitor cells in the absence of myocardial necrosis | 2009 |
|
Dr Arun Natarajan Professor Azfar Zaman
| Non-invasive assessment of saphenous vein graft patency in asymptomatic patients | 2009 |
|
Professor Azfar Zaman
| Percutaneous coronary intervention in anticoagulated patients via radial artery access | 2009 |
|
Professor Azfar Zaman
| Radial artery anomaly and its influence on transradial coronary procedural outcome | 2009 |
|
Professor Vijay Kunadian Professor Azfar Zaman
| Sodium Bicarbonate For The Prevention Of Contrast Induced Nephropathy: A Meta-Analysis | 2009 |
|
Professor Azfar Zaman
| Transradial coronary angiography in children and adolescents | 2009 |
|
Professor Azfar Zaman
| Comparison of operator radiation exposure with optimized radiation protection devices during coronary angiograms and ad hoc percutaneous coronary interventions by radial and femoral routes | 2008 |
|
Professor Vijay Kunadian Professor Azfar Zaman
| Malignancy: An unrecognized risk factor for coronary stent thrombosis? | 2008 |
|
Dr Arun Natarajan Professor Azfar Zaman Emerita Professor Sally Marshall
| Platelet hyperactivity in type 2 diabetes: Role of antiplatelet agents | 2008 |
|
Dr Arun Natarajan Emerita Professor Sally Marshall Professor Azfar Zaman
| The presence of coronary artery disease increases platelet-dependent thrombosis in patients with type 2 diabetes mellitus | 2008 |
|
Dr Arun Natarajan Professor Azfar Zaman
| Antiplatelet therapy in acute coronary syndromes | 2007 |
|
Professor Azfar Zaman
| Incidence of radial artery anatomic variation in patients undergoing transradial coronary angiography and intervention: Influence on procedural outcome. | 2007 |
|
Professor Azfar Zaman
| Incidence of radial artery anatomical variation in patients undergoing transradial coronary angiography and intervention: Influence on procedural outcome | 2007 |
|
Professor Azfar Zaman
| Percutaneous Coronary Revascularization Reduces Plasma N-Terminal Pro-B-Type Natriuretic Peptide Concentration in Stable Coronary Artery Disease | 2007 |
|
Dr Arun Natarajan Professor Azfar Zaman
| Thrombogenicity in type 2 diabetes and coronary artery disease | 2007 |
|
Dr Daniel Birchall Professor Azfar Zaman Emeritus Professor David Mendelow
| Analysis of haemodynamic disturbance in the atherosclerotic carotid artery using computational fluid dynamics | 2006 |
|
Dr Arun Natarajan Emerita Professor Sally Marshall Professor Azfar Zaman
| Blood thrombogenicity is increased in patients with type 2 diabetes mellitus and stable coronary artery disease despite aspirin and statin therapy | 2006 |
|
Professor Azfar Zaman
| Drug Insight: Antithrombotic therapy after percutaneous coronary intervention in patients with an indication for anticoagulation | 2006 |
|
Dr Arun Natarajan Emerita Professor Sally Marshall Professor Azfar Zaman
| Patients with type 2 diabetes mellitus have higher thrombogenicity despite aspirin and statin therapy | 2005 |
|
Dr Arun Natarajan Emerita Professor Sally Marshall Dr John Hanley Professor Azfar Zaman
| Thrombogenicity of flowing blood is increased in patients with type 2 diabetes mellitus (T2DM) despite treatment with aspirin | 2005 |
|
Professor Azfar Zaman
| Angiotensin-converting enzyme inhibitors as adjunctive therapy in patients with persistent atrial fibrillation | 2004 |
|
Dr Ewan Shepherd Dr Chris Plummer Professor Azfar Zaman Dr Janet McComb
| Mortality and symptom benefit with cardiac resynchronisation therapy (CRT) in severe heart failure | 2004 |
|
Professor Azfar Zaman
| Predicting sudden death in patients with mild to moderate chronic heart failure | 2004 |
|
Anthony Hildreth Dr Dominic Cox Professor Azfar Zaman
| Quality of life after percutaneous coronary intervention for patients with previous coronary artery bypass grafting | 2004 |
|
Professor Azfar Zaman
| A prognostic index to predict long-term mortality in patients with mild to moderate chronic heart failure stabilised on angiotensin converting enzyme inhibitors | 2003 |
|
Professor Azfar Zaman
| Coronary angioplasty versus fibrinolytic therapy in acute myocardial infarction | 2003 |
|
Professor Azfar Zaman Dr Asif Shah
| Mortality, autonomic and myocardial abnormalities in chronic heart failure patients with markedly prolonged ventricular activation | 2002 |
|
Professor Azfar Zaman
| Predicting death due to progressive heart failure in patients with mild-to-moderate chronic heart failure | 2002 |
|
Professor Azfar Zaman
| Progression and Regression of Atherosclerotic Lesions Monitoring With Serial Noninvasive Magnetic Resonance Imaging | 2002 |
|
Professor Azfar Zaman
| Blood thrombogenicity in type 2 diabetes mellitus patients is associated with glycemic control | 2001 |
|
Professor Azfar Zaman
| Implementation of the NICE guidelines for the primary prevention of mortality from ventricular tachyarrhythmias: implications for UK electrophysiology centres; activity modelling from the UK-HEART study | 2001 |
|